Clinical Trials for Medigen

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Medigen

Clinical Trials (5)

NCT07088822
A Phase 1 Study Evaluating the Safety, Tolerability, and Immunogenicity of V4020 Vaccine in Healthy Volunteers
PHASE1Not yet recruiting
39 participants
Started: Aug 15, 2025 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT06748872
EPITOME-1015-I: a Study to Investigate the Safety and Tolerability of MDG1015 in Patients with Epithelial Ovarian Cancer, Gastroesophageal Adenocarcinoma, Round Cell Liposarcoma And/or Synovial Sarcoma
PHASE1Not yet recruiting
55 participants
Started: Jul 1, 2025 · Completed: Aug 1, 2042
5 conditions1 sponsor1 location
NCT07178522
A Study to Evaluate the Immunogenicity and Safety of an EV71 Vaccine (Envacgen®) in Children Aged 6 to <10 Years Compared to Children Aged 2 to <6 Years
PHASE3Recruiting
378 participants
Started: Jun 25, 2025 · Completed: Jul 1, 2026
1 condition1 sponsor3 locations
NCT06730009
Phase I/II Study: Allogeneic NK-cell Therapy With Chemotherapy for Post-Surgery PDA or Cholangiocarcinoma Patients
PHASE1/PHASE2Recruiting
42 participants
Started: Oct 21, 2024 · Completed: Aug 31, 2029
2 conditions1 sponsor1 location
NCT05394714
A Phase I, Autologous ex Vivo Expanded and Activated NK Cell, Magicell-NK, Infusion for Colon Cancer Post Resection Study
PHASE1Recruiting
18 participants
Started: Mar 10, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location